ADHD and smoking: From genes to brain to behavior

Annals of the New York Academy of Sciences

Volumn 1141, Issue , 2008, Pages 131-147

  McClernon, Francis Joseph ^a   Kollins, Scott Haden ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Attention deficit hyperactivity disorder; Dopamine; Impulsivity; Nicotine; Nicotine dependence; Smoking

Indexed keywords

AMFEBUTAMONE; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE BETA MONOOXYGENASE; DOPAMINE TRANSPORTER; METHYLPHENIDATE; NICOTINE; NICOTINE PATCH; SEROTONIN; SEROTONIN RECEPTOR; VARENICLINE;

ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CIGARETTE SMOKING; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; DISEASE SEVERITY; GENE LOCUS; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MONOAMINERGIC SYSTEM; NEUROTRANSMISSION; PATIENT COUNSELING; PREVALENCE; RECURRENCE RISK; REVIEW; RISK FACTOR; SMOKING CESSATION; SOCIAL PSYCHOLOGY; TOBACCO DEPENDENCE;

NICOTIANA TABACUM;

EID: 54949151065     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1441.016     Document Type: Review

References (137)

1. Ezzati, M. & A.D. Lopez. 2003. Estimates of global mortality attributable to smoking in 2000. Lancet 362 : 847 852.
2. CDC. 2002. Annual smoking attributable mortality, years of potential life lost, and economic costs - United States, 1995-1999. MMWR 51 : 300 303.
3. Grant, B.F. et al. 2004. Nicotine dependence and psychiatric disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry 61 : 1107 1115.
4. Lasser, K. et al. 2000. Smoking and mental illness: A population-based prevalence study. JAMA 284 : 2606 2610.
5. Breslau, N. 1995. Psychiatric comorbidity of smoking and nicotine dependence. Behav. Genet. 25 : 95 101.
6. John, U. et al. 2004. Smoking, nicotine dependence and psychiatric comorbidity - a population-based study including smoking cessation after three years. Drug Alcohol Depend. 76 : 287 295.
7. Pomerleau, O.F. et al. 1995. Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. J. Subst. Abuse 7 : 373 378.
8. Kollins, S.H. et al. 2005. Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. Arch. Gen. Psychiatry 62 : 1142 1147.
9. APA. 2000. Diagnostic and Statistical Manual of Mental Disorders (text rev). American Psychiatric Association. Washington, DC.
10. Kessler, R.C. et al. 2006. The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. Am. J. Psychiatry 163 : 716 723.
11. Polanczyk, G. et al. 2007. The worldwide prevalence of ADHD: A systematic review and metaregression analysis. Am. J. Psychiatry 164 : 942 948.
12. Pelham, W.E. et al. 2007. The economic impact of attention-deficit/ hyperactivity disorder in children and adolescents. Ambul. Pediatr. 7 : 121 131.
13. Rasmussen, E.R. et al. 2002. Comparison of male adolescent-report of attention-deficit/hyperactivity disorder (ADHD) symptoms across two cultures using latent class and principal components analysis. J. Child Psychol. Psychiatry 43 : 797 805.
14. Tercyak, K.P. et al. 2002. Association of attention-deficit/hyperactivity disorder symptoms with levels of cigarette smoking in a community sample of adolescents. J. Am. Acad. Child Adolesc. Psychiatry 41 : 799 805.
15. Shiffman, S. 1989. Tobacco "chippers" - individual differences in tobacco dependence. Psychopharmacology (Berl.) 97 : 539 547.
16. Donny, E.C. & L.C. Dierker. 2007. The absence of DSM-IV nicotine dependence in moderate-to-heavy daily smokers. Drug Alcohol Depend. 89 : 93 96.
17. CDC. 2002. Cigarette Smoking Among Adults - United States, 2000. MMWR 51 : 642 645.
18. Tucker, J.S. et al. 2003. Predictors of the transition to regular smoking during adolescence and young adulthood. J. Adolesc. Health 32 : 314 324.
19. Gilpin, E.A. et al. 1999. How many adolescents start smoking each day in the United States? J. Adolesc. Health 25 : 248 255.
20. Gritz, E.R. et al. 1991. The tobacco withdrawal syndrome in unaided quitters. Br. J. Addict. 86 : 57 69.
21. Hughes, J.R. et al. 1992. Smoking cessation among self-quitters. Health Psychol. 11 : 331 334.
22. CDC. 2007. Cigarette smoking among adults - United States, 2006. MMWR 56 : 1157 1161.
23. Croghan, G.A. et al. 2003. Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: A minimal intervention, randomized multicenter trial in a nonspecialized setting. Nicotine Tob. Res. 5 : 181 187.
24. Lerman, C. et al. 2004. Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial. Ann. Intern. Med. 140 : 426 433.
25. Nides, M. et al. 2006. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: Results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up. Arch. Intern. Med. 166 : 1561 1568.
26. Milberger, S. et al. 1997. ADHD is associated with early initiation of cigarette smoking in children and adolescents. J. Am. Acad. Child Adolesc. Psychiatry 36 : 37 44.
27. Lambert, N.M. & C.S. Hartsough. 1998. Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. J. Learn Disabil. 31 : 533 544.
28. Molina, B.S. & W.E. Pelham, Jr. 2003. Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J. Abnorm. Psychol. 112 : 497 507.
29. Barkley, R.A. et al. 1990. The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. J. Am. Acad. Child Adolesc. Psychiatry 29 : 546 557.
30. Biederman, J. et al. 1997. Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. J. Am. Acad. Child Adolesc. Psychiatry 36 : 21 29.
31. Boyle, M.H. & D.R. Offord. 1991. Psychiatric disorder and substance use in adolescence. Can. J. Psychiatry 36 : 699 705.
32. Milberger, S. et al. 1997. Associations between ADHD and psychoactive substance use disorders. Findings from a longitudinal study of high-risk siblings of ADHD children. Am. J. Addict. 6 : 318 329.
33. Aytaclar, S. et al. 1999. Association between hyperactivity and executive cognitive functioning in childhood and substance use in early adolescence. J. Am. Acad. Child Adolesc. Psychiatry 38 : 172 178.
34. Burke, J.D. et al. 2001. Which aspects of ADHD are associated with tobacco use in early adolescence? J. Child Psychol. Psychiatry 42 : 493 502.
35. Whalen, C.K. et al. 2002. The ADHD spectrum and everyday life: Experience sampling of adolescent moods, activities, smoking, and drinking. Child Dev. 73 : 209 227.
36. Pomerleau, C.S. et al. 2003. Smoking patterns and abstinence effects in smokers with no ADHD, childhood ADHD, and adult ADHD symptomatology. Addict. Behav. 28 : 1149 1157.
37. Rohde, P. et al. 2004. Psychiatric disorders, familial factors, and cigarette smoking: II. Associations with progression to daily smoking. Nicotine Tob. Res. 6 : 119 132.
38. Fuemmeler, B.F. et al. 2007. Attention deficit hyperactivity disorder symptoms predict nicotine dependence and progression to regular smoking from adolescence to young adulthood. J. Pediatr. Psychol. 32 : 1203 1213.
39. McClernon, F.J. et al. 2008. Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: Results of a preliminary study. Psychopharmacology (Berl.) 46 : 289 297.
40. Humfleet, G.L. et al. 2005. Preliminary evidence of the association between the history of childhood attention-deficit/hyperactivity disorder and smoking treatment failure. Nicotine Tob. Res. 7 : 453 460.
41. Xian, H. et al. 2003. The heritability of failed smoking cessation and nicotine withdrawal in twins who smoked and attempted to quit. Nicotine Tob. Res. 5 : 245 254.
42. Faraone, S.V. et al. 2005. Molecular genetics of attention-deficit/ hyperactivity disorder. Biol. Psychiatry 57 : 1313 1323.
43. Li, M.D. et al. 2003. A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 98 : 23 31.
44. Li, M.D. et al. 2004. Progress in searching for susceptibility loci and genes for smoking-related behaviour. Clin. Genet. 66 : 382 392.
45. Maher, B.S. et al. 2002. Dopamine system genes and attention deficit hyperactivity disorder: A meta-analysis. Psychiatr. Genet. 12 : 207 215.
46. Munafo, M. et al. 2004. The genetic basis for smoking behavior: A systematic review and meta-analysis. Nicotine Tob. Res. 6 : 583 597.
47. Todd, R.D. et al. 2005. Collaborative analysis of DRD4 and DAT genotypes in population-defined ADHD subtypes. J. Child Psychol. Psychiatry. 46 : 1067 1073.
48. McGough, J.J. 2005. Attention-deficit/hyperactivity disorder pharmacogenomics. Biol. Psychiatry 57 : 1367 1373.
49. Hamarman, S. et al. 2004. Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention deficit hyperactivity disorder: A pharmacogenetic study. J. Child Adolesc. Psychopharmacol. 14 : 564 574.
50. Joober, R. et al. 2007. Dopamine transporter 3′-UTR VNTR genotype and ADHD: A pharmaco-behavioural genetic study with methylphenidate. Neuropsychopharmacology 32 : 1370 1376.
51. Stein, M.A. et al. 2005. Dopamine transporter genotype and methylphenidate dose response in children with ADHD. Neuropsychopharmacology 30 : 1374 1382.
52. McGough, J. et al. 2006. Pharmacogenetics of methylphenidate response in preschoolers with ADHD. J. Am. Acad. Child Adolesc. Psychiatry. 45 : 1314 1322.
53. Albayrak, O. et al. 2008. Genetic aspects in attention-deficit/ hyperactivity disorder. J. Neural. Transm. 115 : 305 315.
54. Arcos-Burgos, M. et al. 2004. Attention-deficit/hyperactivity disorder in a population isolate: Linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11. Am. J. Hum. Genet. 75 : 998 1014.
55. Bakker, S.C. et al. 2003. A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: Suggestive evidence for linkage on chromosomes 7p and 15q. Am. J. Hum. Genet. 72 : 1251 1260.
56. Ogdie, M.N. et al. 2003. A genomewide scan for attention-deficit/ hyperactivity disorder in an extended sample: Suggestive linkage on 17p11. Am. J. Hum. Genet. 72 : 1268 1279.
57. Ogdie, M.N. et al. 2006. Pooled genome-wide linkage data on 424 ADHD ASPs suggests genetic heterogeneity and a common risk locus at 5p13. Mol. Psychiatry 11 : 5 8.
58. Hebebrand, J. et al. 2006. A genome-wide scan for attention-deficit/ hyperactivity disorder in 155 German sib-pairs. Mol. Psychiatry 11 : 196 205.
59. Manolio, T.A. et al. 2007. New models of collaboration in genome-wide association studies: The Genetic Association Information Network. Nat. Genet. 39 : 1045 1051.
60. Gerra, G. et al. 2005. Association of the serotonin transporter promoter polymorphism with smoking behavior among adolescents. Am. J. Med. Genet. Part B: Neuropsychiatr. Genet. 135 : 73 78.
61. Hutchison, K.E. et al. 2002. The DRD4 VNTR polymorphism influences reactivity to smoking cues. J. Abnorm. Psychol. 111 : 134 143.
62. Ishikawa, H. et al. 1999. Association between serotonin transporter gene polymorphism and smoking among Japanese males. Cancer Epidemiol. Biomarkers Prev. 8 : 831 833.
63. Lerer, E. et al. 2006. Why do young women smoke? II. Role of traumatic life experience, psychological characteristics and serotonergic genes. Mol. Psychiatry 11 : 771 781.
64. Lerman, C. et al. 1998. Depression and self-medication with nicotine: The modifying influence of the dopamine D4 receptor gene. Health Psychol. 17 : 56 62.
65. Luciano, M. et al. 2004. Effects of dopamine receptor D4 variation on alcohol and tobacco use and on novelty seeking: Multivariate linkage and association analysis. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 124 : 113 123.
66. Skowronek, M.H. et al. 2006. Interaction between the dopamine D4 receptor and the serotonin transporter promoter polymorphisms in alcohol and tobacco use among 15-year-olds. Neurogenetics 7 : 239 246.
67. Timberlake, D.S. et al. 2006. An association between the DAT1 polymorphism and smoking behavior in young adults from the National Longitudinal Study of Adolescent Health. Health Psychol. 25 : 190 197.
68. Tapper, A.R. et al. 2004. Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization. Science 306 : 1029 1032.
69. Sullivan, P.F. et al. 2001. An association study of DRD5 with smoking initiation and progression to nicotine dependence. Am. J. Med. Genet. 105 : 259 265.
70. McClernon, F.J. et al. 2007. DRD4 VNTR polymorphism is associated with transient fMRI-BOLD responses to smoking cues. Psychopharmacology (Berl.) 194 : 433 441.
71. Greenbaum, L. et al. 2006. Why do young women smoke? I. Direct and interactive effects of environment, psychological characteristics and nicotinic cholinergic receptor genes. Mol. Psychiatry 11 : 312 22, 223.
72. Hutchison, K.E. et al. 2007. CHRNA4 and tobacco dependence: From gene regulation to treatment outcome. Arch. Gen. Psychiatry 64 : 1078 1086.
73. Li, M.D. et al. 2005. Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence. Hum. Mol. Genet. 14 : 1211 1219.
74. Ehringer, M.A. et al. 2007. Association of the neuronal nicotinic receptor beta2 subunit gene (CHRNB2) with subjective responses to alcohol and nicotine. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144 : 596 604.
75. Li, M.D. 2008. Identifying susceptibility loci for nicotine dependence: 2008 update based on recent genome-wide linkage analyses. Hum. Genet.
76. Lerman, C.E. et al. 2007. Genetics and smoking cessation improving outcomes in smokers at risk. Am. J. Prev. Med. 33 : S398 S405.
77. Yudkin, P. et al. 2004. Effectiveness of nicotine patches in relation to genotype in women versus men: Randomised controlled trial. BMJ 328 : 989 990.
78. David, S.P. et al. 2007. Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. Nicotine Tob. Res. 9 : 821 833.
79. McClernon, F.J. et al. 2008. Interactions between genotype and retrospective ADHD symptoms predict lifetime smoking risk in a sample of young adults. Nicotine Tob. Res. 10 : 117 127.
80. Neuman, R.J. et al. 2007. Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD subtype. Biol. Psychiatry 61 : 1320 1328.
81. Todd, R.D. & R.J. Neuman. 2007. Gene-environment interactions in the development of combined type ADHD: Evidence for a synapse-based model. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144 : 971 975.
82. Todd, R.D. et al. 2003. Mutational analysis of the nicotinic acetylcholine receptor alpha 4 subunit gene in attention deficit/hyperactivity disorder: Evidence for association of an intronic polymorphism with attention problems. Mol. Psychiatry 8 : 103 108.
83. Kent, L. et al. 2001. Nicotinic acetylcholine receptor alpha4 subunit gene polymorphism and attention deficit hyperactivity disorder. Psychiatr. Genet. 11 : 37 40.
84. Brookes, K. et al. 2006. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: Association signals in DRD4, DAT1 and 16 other genes. Mol. Psychiatry 11 : 934 953.
85. Guan, L. et al. 2008. A high-density single-nucleotide polymorphism screen of 23 candidate genes in attention deficit hyperactivity disorder: Suggesting multiple susceptibility genes among Chinese Han population. Mol. Psychiatry.
86. Lee, J. et al. 2008. Association study of the nicotinic acetylcholine receptor alpha4 subunit gene, CHRNA4, in attention-deficit hyperactivity disorder. Genes Brain Behav. 7 : 53 60.
87. Kent, L. et al. 2001. No association between CHRNA7 microsatellite markers and attention-deficit hyperactivity disorder. Am. J. Med. Genet. 105 : 686 689.
88. Voineskos, S. et al. 2007. Association of alpha4beta2 nicotinic receptor and heavy smoking in schizophrenia. J. Psychiatry Neurosci. 32 : 412 416.
89. Grace, A.A. 2001. Psychostimulant actions on dopamine and limbic system function: Relevance to the pathophysiology and treatment of ADHD. In Stimulant Drugs and ADHD: Basic and Clinical Neuroscience. M.V. Solanto, A.F.T. Arnsten & F.X. Castellanos, Eds 134 157. Oxford University Press. London, United Kingdom.
90. Solanto, M.V. 1998. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav. Brain Res. 94 : 127 152.
91. Spencer, T.J. et al. 2005. In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: A focus on the dopamine transporter. Biol. Psychiatry 57 : 1293 1300.
92. Cheon, K.A. et al. 2003. Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder. Eur. J. Nucl. Med. Mol. Imaging 30 : 306 311.
93. Dougherty, D.D. et al. 1999. Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 354 : 2132 2133.
94. Dresel, S. et al. 2000. Attention deficit hyperactivity disorder: Binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Eur. J. Nucl. Med. 27 : 1518 1524.
95. Krause, K.H. et al. 2000. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: Effects of methylphenidate as measured by single photon emission computed tomography. Neurosci. Lett. 285 : 107 110.
96. Krause, K.H. et al. 2002. Stimulant-like action of nicotine on striatal dopamine transporter in the brain of adults with attention deficit hyperactivity disorder. Int. J. Neuropsychopharmacol. 5 : 111 113.
97. Krause, K.H. et al. 2003. The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder. Neurosci. Biobehav. Rev. 27 : 605 613.
98. Larisch, R. et al. 2006. Striatal dopamine transporter density in drug naive patients with attention-deficit/hyperactivity disorder. Nucl. Med. Commun. 27 : 267 270.
99. Volkow, N.D. et al. 2007. Brain dopamine transporter levels in treatment and drug naive adults with ADHD. Neuroimage 34 : 1182 1190.
100. Corrigall, W.A. et al. 1994. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res. 653 : 278 284.
101. Brody, A.L. et al. 2004. Smoking-induced ventral striatum dopamine release. Am. J. Psychiatry 161 : 1211 1218.
102. Koelega, H.S. 1993. Stimulant drugs and vigilance performance: A review. Psychopharmacology (Berl.) 111 : 1 16.
103. Rezvani, A.H. & E.D. Levin. 2001. Cognitive effects of nicotine. Biol. Psychiatry 49 : 258 267.
104. Hahn, B. & I.P. Stolerman. 2002. Nicotine-induced attentional enhancement in rats: Effects of chronic exposure to nicotine. Neuropsychopharmacology 27 : 712 722.
105. Levin, E.D. et al. 1998. Transdermal nicotine effects on attention. Psychopharmacology (Berl.) 140 : 135 141.
106. Warburton, D.M. & G. Mancuso. 1998. Evaluation of the information processing and mood effects of a transdermal nicotine patch. Psychopharmacology (Berl.) 135 : 305 310.
107. Sacco, K.A. et al. 2005. Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch. Gen. Psychiatry 62 : 649 659.
108. Levin, E.D. et al. 1996. Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl.) 123 : 55 63.
109. Barkley, R.A. 1997. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol. Bull. 121 : 65 94.
110. McClernon, F.J. et al. 2006. Transdermal nicotine attenuates depression symptoms in nonsmokers: A double-blind, placebo-controlled trial. Psychopharmacology (Berl.) 189 : 125 133.
111. Potter, A.S. & P.A. Newhouse. 2004. Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/ hyperactivity disorder. Psychopharmacology (Berl.) 176 : 182 194.
112. Potter, A.S. & P.A. Newhouse. 2008. Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder. Pharmacol. Biochem. Behav. 88 : 407 417.
113. Levin, E.D. et al. 2001. Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder. Exp. Clin. Psychopharmacol. 9 : 83 90.
114. Wilens, T.E. et al. 1999. A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder. Am. J. Psychiatry 156 : 1931 1937.
115. Wilens, T.E. et al. 2006. ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit/hyperactivity disorder in adults: Results of a pilot study. Biol. Psychiatry 59 : 1065 1070.
116. Downey, K.K. et al. 1996. Personality differences related to smoking and adult attention deficit hyperactivity disorder. J. Subst. Abuse 8 : 129 135.
117. Bagwell, C.L. et al. 2001. Attention-deficit hyperactivity disorder and problems in peer relations: Predictions from childhood to adolescence. J. Am. Acad. Child Adolesc. Psychiatry 40 : 1285 1292.
118. Doran, N. et al. 2004. Impulsivity and smoking relapse. Nicotine Tob. Res. 6 : 641 647.
119. DuBois, D.L. & N. Silverthorn. 2004. Do deviant peer associations mediate the contributions of self-esteem to problem behavior during early adolescence? A 2-year longitudinal study. J. Clin. Child Adolesc. Psychol. 33 : 382 388.
120. Lejuez, C.W. et al. 2003. The Balloon Analogue Risk Task (BART) differentiates smokers and nonsmokers. Exp. Clin. Psychopharmacol. 11 : 26 33.
121. Mitchell, S.H. 1999. Measures of impulsivity in cigarette smokers and non-smokers. Psychopharmacology (Berl.) 146 : 455 464.
122. Pomerleau, C.S. 1997. Co-factors for smoking and evolutionary psychobiology. Addiction 92 : 397 408.
123. Reynolds, B. et al. 2004. Delay discounting and probability discounting as related to cigarette smoking status in adults. Behav. Processes 65 : 35 42.
124. Finzi-Dottan, R. et al. 2006. ADHD, temperament, and parental style as predictors of the child's attachment patterns. Child Psychiatry. Hum. Dev. 37 : 103 114.
125. Harakeh, Z. et al. 2004. Parental factors and adolescents' smoking behavior: An extension of the theory of planned behavior. Prev. Med. 39 : 951 961.
126. Laucht, M. et al. 2007. Association between ADHD and smoking in adolescence: Shared genetic, environmental and psychopathological factors. J. Neural. Transm. 114 : 1097 1104.
127. Marshal, M.P. & B.S. Molina. 2006. Antisocial behaviors moderate the deviant peer pathway to substance use in children with ADHD. J. Clin. Child Adolesc. Psychol. 35 : 216 226.
128. Simons-Morton, B. et al. 2001. Peer and parent influences on smoking and drinking among early adolescents. Health Educ. Behav. 28 : 95 107.
129. Dobbins, M. et al. 2007. Effective practices for school-based tobacco use prevention. Prev. Med. 46 : 289 297.
130. Thomas, R. & R. Perera. 2006. School-based programmes for preventing smoking. Cochrane Database Syst. Rev. 3 : CD001293.
131. Hoza, B. 2007. Peer functioning in children with ADHD. J. Pediatr. Psychol. 32 : 655 663.
132. Molina, B.S. et al. 2005. Coping skills and parent support mediate the association between childhood attention-deficit/hyperactivity disorder and adolescent cigarette use. J. Pediatr. Psychol. 30 : 345 357.
133. Dwoskin, L.P. et al. 2006. Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. CNS Drug Rev. 12 : 178 207.
134. Wilens, T.E. et al. 2005. Bupropion XL in adults with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled study. Biol. Psychiatry 57 : 793 801.
135. Monuteaux, M.C. et al. 2007. A randomized, placebo-controlled clinical trial of bupropion for the prevention of smoking in children and adolescents with attention-deficit/hyperactivity disorder. J. Clin. Psychiatry 68 : 1094 1101.
136. Upadhyaya, H.P. et al. 2004. Bupropion SR in adolescents with comorbid ADHD and nicotine dependence: A pilot study. J. Am. Acad. Child Adolesc. Psychiatry 43 : 199 205.
137. Safren, S.A. 2006. Cognitive-behavioral approaches to ADHD treatment in adulthood. J. Clin. Psychiatry 67 (Suppl 8 46 50.